| Product Code: ETC11700165 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China AAV Contract Development Manufacturing Organizations Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, 2021 & 2031F |
3.3 China AAV Contract Development Manufacturing Organizations Market - Industry Life Cycle |
3.4 China AAV Contract Development Manufacturing Organizations Market - Porter's Five Forces |
3.5 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.7 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume Share, By End User (Biotech), 2021 & 2031F |
4 China AAV Contract Development Manufacturing Organizations Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for gene therapy and gene editing technologies in China |
4.2.2 Government initiatives and policies promoting the biopharmaceutical industry |
4.2.3 Growth in collaborations and partnerships between Chinese and international companies in the biotech sector |
4.3 Market Restraints |
4.3.1 Regulatory challenges and complexities in the gene therapy market in China |
4.3.2 Lack of skilled workforce and expertise in AAV contract development and manufacturing |
4.3.3 Intense competition from established global CDMOs (Contract Development and Manufacturing Organizations) |
5 China AAV Contract Development Manufacturing Organizations Market Trends |
6 China AAV Contract Development Manufacturing Organizations Market, By Types |
6.1 China AAV Contract Development Manufacturing Organizations Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Vector Manufacturing, 2021 - 2031F |
6.1.4 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Process Development, 2021 - 2031F |
6.1.5 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Quality Control, 2021 - 2031F |
6.1.6 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Clinical Manufacturing, 2021 - 2031F |
6.2 China AAV Contract Development Manufacturing Organizations Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.2.3 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.2.4 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.5 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.3 China AAV Contract Development Manufacturing Organizations Market, By End User (Biotech) |
6.3.1 Overview and Analysis |
6.3.2 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Biopharma Companies, 2021 - 2031F |
6.3.3 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.4 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Small/Midsize Biotechs, 2021 - 2031F |
6.3.5 China AAV Contract Development Manufacturing Organizations Market Revenues & Volume, By Large Pharma, 2021 - 2031F |
7 China AAV Contract Development Manufacturing Organizations Market Import-Export Trade Statistics |
7.1 China AAV Contract Development Manufacturing Organizations Market Export to Major Countries |
7.2 China AAV Contract Development Manufacturing Organizations Market Imports from Major Countries |
8 China AAV Contract Development Manufacturing Organizations Market Key Performance Indicators |
8.1 Percentage of RD investment in gene therapy and gene editing technologies in China |
8.2 Number of new partnerships and collaborations formed by Chinese AAV CDMOs |
8.3 Average time-to-market for AAV-based gene therapy products in China |
9 China AAV Contract Development Manufacturing Organizations Market - Opportunity Assessment |
9.1 China AAV Contract Development Manufacturing Organizations Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 China AAV Contract Development Manufacturing Organizations Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.3 China AAV Contract Development Manufacturing Organizations Market Opportunity Assessment, By End User (Biotech), 2021 & 2031F |
10 China AAV Contract Development Manufacturing Organizations Market - Competitive Landscape |
10.1 China AAV Contract Development Manufacturing Organizations Market Revenue Share, By Companies, 2024 |
10.2 China AAV Contract Development Manufacturing Organizations Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here